New tricks from an old dog: Mitochondrial redox signaling in cellular inflammation

Seminars in Immunology

Volumn 24, Issue 6, 2012, Pages 384-392

  Pelletier, Martin ^a   Lepow, Talya S ^a   Billingham, Leah K ^a   Murphy, Michael P ^b   Siegel, Richard M ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Inflammation; Metabolism; Mitochondria; Reactive oxygen species; Signaling

Indexed keywords

CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; STAT3 PROTEIN; SUPEROXIDE DISMUTASE;

BINDING SITE; CELL DEATH; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HOST RESISTANCE; HUMAN; HYDROXYLATION; INFLAMMATION; INNATE IMMUNITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATION; PROTEIN BINDING; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

CELL COMMUNICATION; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MITOCHONDRIA; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84874266256     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.01.002     Document Type: Review

References (117)

1. Murphy M.P., Holmgren A., Larsson N.G., Halliwell B., Chang C.J., Kalyanaraman B., et al. Unraveling the biological roles of reactive oxygen species. Cell Metabolism 2011, 13:361-366.
2. Finkel T. Signal transduction by reactive oxygen species. The Journal of Cell Biology 2011, 194:7-15.
3. Janssen-Heininger Y.M., Mossman B.T., Heintz N.H., Forman H.J., Kalyanaraman B., Finkel T., et al. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radical Biology & Medicine 2008, 45:1-17.
4. Murphy M.P. Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications. Antioxidants and Redox Signalling 2012, 16:476-495.
5. 2, a necessary evil for cell signaling. Science 2006, 312:1882-1883.
6. Boivin B., Yang M., Tonks N.K. Targeting the reversibly oxidized protein tyrosine phosphatase superfamily. Science Signaling 2010, 3:pl2.
7. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007, 87:245-313.
8. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nature Reviews: Immunology 2004, 4:181-189.
9. Roos D., Kuhns D.B., Maddalena A., Roesler J., Lopez J.A., Ariga T., et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells, Molecules, and Diseases 2010, 45:246-265.
10. Thorp E., Vaisar T., Subramanian M., Mautner L., Blobel C., Tabas I. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cdelta, and p38 mitogen-activated protein kinase (MAPK). Journal of Biological Chemistry 2011, 286:33335-33344.
11. Li Q., Spencer N.Y., Oakley F.D., Buettner G.R., Engelhardt J.F. Endosomal Nox2 facilitates redox-dependent induction of NF-kappaB by TNF-alpha. Antioxidants and Redox Signalling 2009, 11:1249-1263.
12. Zhang W.J., Wei H., Tien Y.T., Frei B. Genetic ablation of phagocytic NADPH oxidase in mice limits TNFalpha-induced inflammation in the lungs but not other tissues. Free Radical Biology and Medicine 2011, 50:1517-1525.
13. Yazdanpanah B., Wiegmann K., Tchikov V., Krut O., Pongratz C., Schramm M., et al. Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature 2009, 460:1159-1163.
14. Pollock J.D., Williams D.A., Gifford M.A., Li L.L., Du X., Fisherman J., et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genetics 1995, 9:202-209.
15. Lee K., Won H.Y., Bae M.A., Hong J.H., Hwang E.S. Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:9548-9553.
16. van de Loo F.A., Bennink M.B., Arntz O.J., Smeets R.L., Lubberts E., Joosten L.A., et al. Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models. American Journal of Pathology 2003, 163:1525-1537.
17. Hultqvist M., Olofsson P., Holmberg J., Backstrom B.T., Tordsson J., Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:12646-12651.
18. van de Veerdonk F.L., Smeekens S.P., Joosten L.A., Kullberg B.J., Dinarello C.A., van der Meer J.W., et al. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3030-3033.
19. Coant N., Ben Mkaddem S., Pedruzzi E., Guichard C., Treton X., Ducroc R., et al. NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Molecular and Cellular Biology 2010, 30:2636-2650.
20. Kim G.Y., Lee J.W., Ryu H.C., Wei J.D., Seong C.M., Kim J.H. Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis. Journal of Immunology 2010, 184:3946-3954.
21. Ibi M., Matsuno K., Shiba D., Katsuyama M., Iwata K., Kakehi T., et al. Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. Journal of Neuroscience 2008, 28:9486-9494.
22. Kim Y.S., Morgan M.J., Choksi S., Liu Z.G. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Molecular Cell 2007, 26:675-687.
23. Lee S., Gharavi N.M., Honda H., Chang I., Kim B., Jen N., et al. A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids. Free Radical Biology and Medicine 2009, 47:145-151.
24. Ngkelo A., Meja K., Yeadon M., Adcock I., Kirkham P.A. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gialpha dependent PI-3kinase signalling. Journal of Inflammation (London) 2012, 9:1.
25. Rada B., Leto T.L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contributions to Microbiology 2008, 15:164-187.
26. Van Buul J.D., Fernandez-Borja M., Anthony E.C., Hordijk P.L. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxidants and Redox Signalling 2005, 7:308-317.
27. Ago T., Kuroda J., Pain J., Fu C., Li H., Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circulation Research 2010, 106:1253-1264.
28. Montezano A.C., Burger D., Paravicini T.M., Chignalia A.Z., Yusuf H., Almasri M., et al. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circulation Research 2010, 106:1363-1373.
29. Joo J.H., Ryu J.H., Kim C.H., Kim H.J., Suh M.S., Kim J.O., et al. Dual oxidase 2 is essential for the toll-like receptor 5-mediated inflammatory response in airway mucosa. Antioxidants and Redox Signalling 2011, 16:57-70.
30. Poss W.B., Huecksteadt T.P., Panus P.C., Freeman B.A., Hoidal J.R. Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. The American Journal of Physiology 1996, 270:L941-L946.
31. Zanotto-Filho A., Schroder R., Moreira J.C. Differential effects of retinol and retinoic acid on cell proliferation: a role for reactive species and redox-dependent mechanisms in retinol supplementation. Free Radical Research 2008, 42:778-788.
32. Papi A., Contoli M., Gasparini P., Bristot L., Edwards M.R., Chicca M., et al. Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells. The Journal of Biological Chemistry 2008, 283:28595-28606.
33. Hartney T., Birari R., Venkataraman S., Villegas L., Martinez M., Black S.M., et al. Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia. PLoS ONE 2011, 6:e27531.
34. Wang Y., Casero R.A. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?. Journal of Biochemistry 2006, 139:17-25.
35. Babbar N., Casero R.A. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Research 2006, 66:11125-11130.
36. Zangar R.C., Davydov D.R., Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicology and Applied Pharmacology 2004, 199:316-331.
37. Di Lisa F., Kaludercic N., Carpi A., Menabo R., Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Research in Cardiology 2009, 104:131-139.
38. Murphy M.P. How mitochondria produce reactive oxygen species. The Biochemical Journal 2009, 417:1-13.
39. Collins Y., Chouchani E.T., James A.M., Menger K.E., Cocheme H.M., Murphy M.P. Mitochondrial redox signalling at a glance. Journal of Cell Science 2012, 125:801-806.
40. Cao Z., Lindsay J.G., Isaacs N.W. Mitochondrial peroxiredoxins. Sub-Cellular Biochemistry 2007, 44:295-315.
41. Lubos E., Loscalzo J., Handy D.E. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxidants and Redox Signalling 2011, 15:1957-1997.
42. Marchi S., Giorgi C., Suski J.M., Agnoletto C., Bononi A., Bonora M., et al. Mitochondria-ros crosstalk in the control of cell death and aging. Journal of Signal Transduction 2012, 2012:329635.
43. Brand M.D. The sites and topology of mitochondrial superoxide production. Experimental Gerontology 2010, 45:466-472.
44. St-Pierre J., Buckingham J.A., Roebuck S.J., Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. The Journal of Biological Chemistry 2002, 277:44784-44790.
45. Yamagishi S.I., Edelstein D., Du X.L., Kaneda Y., Guzman M., Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. The Journal of Biological Chemistry 2001, 276:25096-25100.
46. Echtay K.S., Roussel D., St-Pierre J., Jekabsons M.B., Cadenas S., Stuart J.A., et al. Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415:96-99.
47. West A.P., Shadel G.S., Ghosh S. Mitochondria in innate immune responses. Nature Reviews: Immunology 2011, 11:389-402.
48. Naik E., Dixit V.M. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. The Journal of Experimental Medicine 2011, 208:417-420.
49. Koshiba T., Yasukawa K., Yanagi Y., Kawabata S. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Science Signaling 2011, 4:ra7.
50. Arnoult D., Soares F., Tattoli I., Castanier C., Philpott D.J., Girardin S.E. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. Journal of Cell Science 2009, 122:3161-3168.
51. Moore C.B., Bergstralh D.T., Duncan J.A., Lei Y., Morrison T.E., Zimmermann A.G., et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-577.
52. Tattoli I., Carneiro L.A., Jehanno M., Magalhaes J.G., Shu Y., Philpott D.J., et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Reports 2008, 9:293-300.
53. Rebsamen M., Vazquez J., Tardivel A., Guarda G., Curran J., Tschopp J. NLRX1/NOD5 deficiency does not affect MAVS signalling. Cell Death and Differentiation 2011, 18:1387.
54. Wu J.J., Quijano C., Chen E., Liu H., Cao L., Fergusson M.M., et al. Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy. Aging 2009, 1:425-437.
55. Tal M.C., Sasai M., Lee H.K., Yordy B., Shadel G.S., Iwasaki A. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2770-2775.
56. Jounai N., Takeshita F., Kobiyama K., Sawano A., Miyawaki A., Xin K.Q., et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14050-14055.
57. Rousset S., Emre Y., Join-Lambert O., Hurtaud C., Ricquier D., Cassard-Doulcier A.M. The uncoupling protein 2 modulates the cytokine balance in innate immunity. Cytokine 2006, 35:135-142.
58. Emre Y., Hurtaud C., Nubel T., Criscuolo F., Ricquier D., Cassard-Doulcier A.M. Mitochondria contribute to LPS-induced MAPK activation via uncoupling protein UCP2 in macrophages. The Biochemical Journal 2007, 402:271-278.
59. Nishio K., Qiao S., Yamashita H. Characterization of the differential expression of uncoupling protein 2 and ROS production in differentiated mouse macrophage-cells (Mm1) and the progenitor cells (M1). Journal of Molecular Histology 2005, 36:35-44.
60. Kopp E., Medzhitov R., Carothers J., Xiao C., Douglas I., Janeway C.A., et al. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes & Development 1999, 13:2059-2071.
61. Vogel R.O., Janssen R.J., van den Brand M.A., Dieteren C.E., Verkaart S., Koopman W.J., et al. Cytosolic signaling protein Ecsit also localizes to mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly. Genes & Development 2007, 21:615-624.
62. West A.P., Brodsky I.E., Rahner C., Woo D.K., Erdjument-Bromage H., Tempst P., et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480.
63. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature Immunology 2010, 11:136-140.
64. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunology 2011, 12:222-230.
65. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
66. Tarallo V., Hirano Y., Gelfand B.D., Dridi S., Kerur N., Kim Y., et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012, 149:847-859.
67. De Nardo D., Latz E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends in Immunology 2011, 32:373-379.
68. Kamata H., Honda S., Maeda S., Chang L., Hirata H., Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661.
69. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:11715-11720.
70. 2 sensing. Journal of Biological Chemistry 2000, 275:25130-25138.
71. Dagenais M., Skeldon A., Saleh M. The inflammasome: in memory of Dr. Jurg Tschopp. Cell Death and Differentiation 2012, 19:5-12.
72. Yu F.X., Chai T.F., He H., Hagen T., Luo Y. Thioredoxin-interacting protein (TXNIP) gene expression: sensing oxidative phosphorylation status and glycolytic rate. Journal of Biological Chemistry 2010, 285:25822-25830.
73. Chen C.L., Lin C.F., Chang W.T., Huang W.C., Teng C.F., Lin Y.S. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 2008, 111:4365-4374.
74. Bauernfeind F., Bartok E., Rieger A., Franchi L., Nunez G., Hornung V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. Journal of Immunology 2011, 187:613-617.
75. McDermott M.F., Aksentijevich I., Galon J., McDermott E.M., Ogunkolade B.W., Centola M., et al. Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999, 97:133-144.
76. Chen L., Liu L., Yin J., Luo Y., Huang S. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. International Journal of Biochemistry and Cell Biology 2009, 41:1284-1295.
77. Bulua A.C., Simon A., Maddipati R., Pelletier M., Park H., Kim K.Y., et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). The Journal of Experimental Medicine 2011, 208:519-533.
78. Smith R.A., Kelso G.F., James A.M., Murphy M.P. Targeting coenzyme Q derivatives to mitochondria. Methods in Enzymology 2004, 382:45-67.
79. Kominsky D.J., Campbell E.L., Colgan S.P. Metabolic shifts in immunity and inflammation. Journal of Immunology 2010, 184:4062-4068.
80. Cicchetti G., Allen P.G., Glogauer M. Chemotactic signaling pathways in neutrophils: from receptor to actin assembly. Critical Reviews in Oral Biology and Medicine 2002, 13:220-228.
81. Borregaard N., Herlin T. Energy metabolism of human neutrophils during phagocytosis. Journal of Clinical Investigation 1982, 70:550-557.
82. Lewis J.S., Lee J.A., Underwood J.C., Harris A.L., Lewis C.E. Macrophage responses to hypoxia: relevance to disease mechanisms. Journal of Leukocyte Biology 1999, 66:889-900.
83. Zucker-Franklin D. Electron microscopic studies of human granulocytes: structural variations related to function. Seminars in Hematology 1968, 5:109-133.
84. Maianski N.A., Geissler J., Srinivasula S.M., Alnemri E.S., Roos D., Kuijpers T.W. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death and Differentiation 2004, 11:143-153.
85. van Raam B.J., Sluiter W., de Wit E., Roos D., Verhoeven A.J., Kuijpers T.W. Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation. PLoS ONE 2008, 3:e2013.
86. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657.
87. Elks P.M., van Eeden F.J., Dixon G., Wang X., Reyes-Aldasoro C.C., Ingham P.W., et al. Activation of hypoxia-inducible factor-1alpha (Hif-1alpha) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood 2011, 118:712-722.
88. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275.
89. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Science's STKE 2007, 2007:cm8.
90. Pan Y., Mansfield K.D., Bertozzi C.C., Rudenko V., Chan D.A., Giaccia A.J., et al. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Molecular and Cellular Biology 2007, 27:912-925.
91. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. Journal of Clinical Investigation 2005, 115:1806-1815.
92. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811.
93. Blouin C.C., Page E.L., Soucy G.M., Richard D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 2004, 103:1124-1130.
94. Hollander A.P., Corke K.P., Freemont A.J., Lewis C.E. Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis and Rheumatism 2001, 44:1540-1544.
95. Krawczyk C.M., Holowka T., Sun J., Blagih J., Amiel E., DeBerardinis R.J., et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010, 115:4742-4749.
96. Everts B., Amiel E., van der Windt G.J., Freitas T.C., Chott R., Yarasheski K.E., et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 2012, 120:1422-1431.
97. Maciver N.J., Jacobs S.R., Wieman H.L., Wofford J.A., Coloff J.L., Rathmell J.C. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. Journal of Leukocyte Biology 2008, 84:949-957.
98. Jones R.G., Thompson C.B. Revving the engine: signal transduction fuels T cell activation. Immunity 2007, 27:173-178.
99. Fox C.J., Hammerman P.S., Thompson C.B. Fuel feeds function: energy metabolism and the T-cell response. Nature Reviews: Immunology 2005, 5:844-852.
100. Jacobs S.R., Herman C.E., Maciver N.J., Wofford J.A., Wieman H.L., Hammen J.J., et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. Journal of Immunology 2008, 180:4476-4486.
101. Doughty C.A., Bleiman B.F., Wagner D.J., Dufort F.J., Mataraza J.M., Roberts M.F., et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 2006, 107:4458-4465.
102. Vander Heiden M.G., Plas D.R., Rathmell J.C., Fox C.J., Harris M.H., Thompson C.B. Growth factors can influence cell growth and survival through effects on glucose metabolism. Molecular and Cellular Biology 2001, 21:5899-5912.
103. Calo V., Migliavacca M., Bazan V., Macaluso M., Buscemi M., Gebbia N., et al. STAT proteins: from normal control of cellular events to tumorigenesis. Journal of Cellular Physiology 2003, 197:157-168.
104. Chen Z., Laurence A., O'Shea J.J. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Seminars in Immunology 2007, 19:400-408.
105. Sarafian T.A., Montes C., Imura T., Qi J., Coppola G., Geschwind D.H., et al. Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro. PLoS ONE 2010, 5:e9532.
106. Wegrzyn J., Potla R., Chwae Y.J., Sepuri N.B., Zhang Q., Koeck T., et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009, 323:793-797.
107. Shulga N., Pastorino J.G. GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. Journal of Cell Science 2012, 125:2995-3003.
108. Goldbach-Mansky R. Blocking interleukin-1 in rheumatic diseases. Annals of the New York Academy of Sciences 2009, 1182:111-123.
109. Sibley C.H., Plass N., Snow J., Wiggs E.A., Brewer C.C., King K.A., et al. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes. Arthritis and Rheumatism 2012, 64:2375-2386.
110. Kastner D., Aksentijevich I., Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell 2010, 140:784-790.
111. Bulua A.C., Mogul D.B., Aksentijevich I., Singh H., He D., Muenz L., et al. Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Arthritis and Rheumatism 2011, 64:908-913.
112. Smith R.A., Hartley R.C., Cocheme H.M., Murphy M.P. Mitochondrial pharmacology. Trends in Pharmacological Sciences 2012, 33:341-352.
113. Smith R.A., Hartley R.C., Murphy M.P. Mitochondria-targeted small molecule therapeutics and probes. Antioxidants and Redox Signalling 2011, 15:3021-3038.
114. Lowes D.A., Thottakam B.M., Webster N.R., Murphy M.P., Galley H.F. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radical Biology and Medicine 2008, 45:1559-1565.
115. Chacko B.K., Reily C., Srivastava A., Johnson M.S., Ye Y., Ulasova E., et al. Prevention of diabetic nephropathy in Ins2(+/)(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochemical Journal 2010, 432:9-19.
116. Snow B.J., Rolfe F.L., Lockhart M.M., Frampton C.M., O'Sullivan J.D., Fung V., et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Movement Disorders 2010, 25:1670-1674.
117. Gane E.J., Weilert F., Orr D.W., Keogh G.F., Gibson M., Lockhart M.M., et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a Phase II study of hepatitis C patients. Liver International 2010, 30:1019-1026.